Welcome to the Allergy Therapeutics Investor Relations Centre.

"We continue to execute our strategy to create significant value for our shareholders."

Manuel Llobet - CEO
Full Year results for year ending 30 June 2021

The Interim results for year ending 30 June 2021 will be announced on 23 September 2021

Annual Report 2020